Tianjin TEDA Biomedical Engineering Company Limited expects that there will be a delay in the publication of the annual report for the year on the website established by the Stock Exchange for GEM and the despatch of the annual report for the year to the holders of shares ("Shareholders"), and it is unlikely to be completed by 31 March 2022 (i.e. the time that the annual report should be despatched to the Shareholders by the Company as required under the Rules Governing the Listing of Securities on GEM of the Stock Exchange ("GEM Listing Rules")). The Company expects that the annual report for the year will be published and despatched to the Shareholders no later than 30 April 2022.
Tianjin TEDA Biomedical Engineering Company Limited
Equities
8189
CNE1000004H7
Agricultural Chemicals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.075 HKD | 0.00% | -10.71% | -15.73% |
1st Jan change | Capi. | |
---|---|---|
-15.73% | 18.15M | |
+1.40% | 15.02B | |
-14.18% | 14.5B | |
+6.58% | 12.19B | |
-13.77% | 9.72B | |
-12.35% | 7.35B | |
-.--% | 7.31B | |
-3.81% | 4.18B | |
-27.17% | 2.37B | |
+2.63% | 2.06B |
- Stock Market
- Equities
- 8189 Stock
- News Tianjin TEDA Biomedical Engineering Company Limited
- Tianjin Teda Biomedical Engineering Company Limited Announces Delay in Publication and Despatch of Annual Report for the Year